Skip to main content

David Chao

Equibles does not estimate personal net worth.

Get an email with a short summary when AvePoint, Inc. publishes a filing, an earnings call transcript or a press release.

Get AVPT alerts

About David Chao

David Chao is recorded as Board Member at AvePoint, Inc. (AVPT). The newest filing on record that lists David Chao as Board Member at AvePoint, Inc. (AVPT) is dated December 8, 2020. Earlier roles on record: Board Member at BILL Holdings, Inc. (BILL) until December 3, 2020. The proxy statement of Centessa Pharmaceuticals plc reports total compensation of $1,317,905 for David Chao in fiscal 2023, including a base salary of $493,700. Disclosed compensation is on record for 3 fiscal years. AvePoint, Inc. is classified in the Software - Infrastructure industry within the Technology sector. Other leadership on record at AvePoint, Inc. includes Tianyi Jiang (CEO), Xunkai Gong (Chairman), James (Jim) Caci (CFO) and 6 others.

Affiliation history

Company network

Current role

Software - Infrastructure · Technology

Board Member

Leadership on record at AvePoint, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Centessa Pharmaceuticals plc (CNTA) $493,700 $1,317,905
2022 Centessa Pharmaceuticals plc (CNTA) $465,800 $3,309,069
2021 Centessa Pharmaceuticals plc (CNTA) $303,864 $3,962,067

Recent activity

No call appearances or filed executive changes recorded yet.